CHROMOCELL THERAPEUTICS CORPORATION

Other languages Chromocell Therapeutics Corporation

Equities

CHRO

US1711261057

Market Closed - Nyse Other stock markets 04:10:00 2024-06-07 pm EDT			5-day change	1st Jan Change
1.42 ^USD	-4.05%		+5.97%	0.00%

May. 15	Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 16	Chromocell Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15
Chromocell Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16
Chromocell Therapeutics Corporation Announces Formal Launch of Eye Pain Treatment Program	Mar. 21
Chromocell Therapeutics Corp. Appoints Frank Knuettel, Interim CEO, as Permanent CEO	Mar. 18
Chromocell Therapeutics Corporation has completed an IPO in the amount of $6.6 million.	Feb. 15
Chromocell Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Jan. 16
Chromocell Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-09-01
Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-06-30
Chromocell Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
CHRO Stock
News Chromocell Therapeutics Corporation
Other languages

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer